Patent · US Active

Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markers

US8329651B2 · kind B2 · utility

0Cited by
5References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2009
Grant dateDec 11, 2012
Priority date—
Expiry dateJun 17, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Use of Annexin A1 or Rab23 as a biomarker for diagnosing kidney disease or assessing efficacy of kidney disease treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.